Ignite Creation Date:
2025-12-25 @ 12:43 AM
Ignite Modification Date:
2026-05-03 @ 4:08 PM
Study NCT ID:
NCT00094367
Status:
COMPLETED
Last Update Posted:
2010-09-30
First Post:
2004-10-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
101822
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
GSK